Tom Rosenberg

Tom Rosenberg, MD is an Attending Physician in Pediatric Neuro-Oncology and Clinical Assistant Professor of Pediatrics at Harvard Medical School, based at Dana-Farber/Boston Children's Cancer and Blood Disorders Center in Boston, Massachusetts. His clinical practice focuses on treating complex pediatric brain tumors.

Dr. Rosenberg completed his medical education at Ben Gurion University in Beer Sheva, Israel in 2010, followed by Pediatrics Residency at Tel Aviv Medical Center (2017), Pediatric Hematology/Oncology Fellowship at Tel Aviv Medical Center (2020), and Pediatric Neuro-Oncology Fellowship at Dana-Farber/Boston Children's Cancer and Blood Disorders Center (2021).

His research interests center on pediatric neuro-oncology, particularly brain tumors, glioma, medulloblastoma, atypical teratoid rhabdoid tumor, and germ cell tumors. Dr. Rosenberg's work explores molecular genetics, targeted therapies, and precision medicine approaches for childhood brain cancers. His recent publications reflect a strong focus on molecular profiling, genomic landscapes, and novel therapeutic approaches for pediatric brain tumors.

His research demonstrates an evolving trend toward increasingly sophisticated molecular characterization of pediatric brain tumors, with growing emphasis on precision medicine approaches and targeted therapies. The publications span multiple high-impact journals including Cell Reports Medicine, Neuro-Oncology, and Neoplasia, indicating significant contributions to the field.

Dr. Rosenberg is actively involved in clinical care at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, where he treats patients with various brain tumors including ATRT, Craniopharyngioma, Germ Cell Brain Tumors, Germinoma, Glioma, Low-Grade Gliomas, and Medulloblastoma. His clinical work is closely integrated with research efforts to advance treatment options for children with neuro-oncological conditions.